Oligodendrocytes, myelin-forming glia in the central nervous system (CNS), are the last major type of 3 neural cells formed during the CNS development. Although the process of oligodendrogenesis has 4 been relatively well delineated in the rodent brain at embryonic and early postnatal stages, it remains 5 largely unknown whether analogous developmental processes are manifested in the human brain.
2 Introduction 1 2
Oligodendrocytes are the myelinating cells in the central nervous system (CNS) and are the last major 3 type of neural cells formed during the CNS development (Goldman and Kuypers, 2015; Zhong et al., 4 2018) . While myelination is most notable in the white matter, myelinating oligodendrocytes are also 5 present in the grey matter, such as cerebral cortex. Much of our current knowledge on oligodendrocyte
The nuclear vs. cytoplasmic localization of Olig2 in NPCs is likely an indication of fate 23 commitment of the cells. Nuclear localization of Olig2 suggests differentiation to oligodendroglial 24 lineage cells (Ligon et al., 2006) , whereas cytoplasmic localization suggests differentiation to neuronal 25 or astroglial cells (Setoguchi and Kondo, 2004; Takebayashi et al., 2000; Zhao et al., 2009 ). To 26 delineate the cell identities, particularly the identity of GFP + cells, we immuno-stained the organoids 27 with astroglial marker S100β or neuronal marker β IIIT. As shown in Fig. 3C , a large number of β IIIT + 28 neurons and a small population of S100β + astrocytes were identified in 6-week-old DFOs. The GFP + 29 NPCs in DFOs mainly differentiated into neurons with a small percent giving rise to astroglia ( Fig. 3D;   30 3.1 ± 0.2 and 28.7 ± 4.5 % of GFP + cells expressed S100β and β IIIT, respectively; n = 3). PDGFRα + 31 OPCs, however, were not detected (data not shown) in week 6 DFOs. In addition, we double-stained 32 the DFOs with GFP and DCX, a marker for migrating immature neurons (Gleeson et al., 1999) , or 33 TBR2, a marker for intermediate neuronal progenitors (Sessa et al., 2010) . We found that there were 34 GFP + /DCX + processes and that some GFP + cells were positive for TBR2 ( Fig. 3E) , further suggesting 35 that these GFP + /OLIG2 + cells were able to differentiate to neuronal cells.
36
A previous fate-mapping study in mice has clearly demonstrated that a fraction of Olig2-37 expressing NPCs in the telecephalon and diencephalon in the fetal forebrain develop into glutamatergic 38 neurons (Ono et al., 2008) . We found the formation of glutamatergic synapses in week 7 DFOs, as 39 indicated by the staining of VGLUT1 + puncta (Fig. 3G) . Notably, some of the VGLUT1 + puncta were 40 found to distribute along the GFP + processes. This prompted us to further characterize whether the 41 OLIG2 + cells in the DFOs could also give rise to glutamatergic neurons. We triple-stained the week 7 48 During embryonic brain development, neurogenesis precedes gliogenesis. Oligodendroglia is the last 49 type of glial cells formed during brain development. In addition, mounting evidence suggests that 50 neuronal maturation and activity influence oligodendrogenesis and myelination (Gibson et al., 2014;  51 1 inorganic salts, neuroactive amino acids, and energetic substrates to better support the 2 neurophysiological activity of cultured human neurons (Bardy et al., 2015) . We further cultured DFOs 3 and VFOs in the BrainPhys medium from week 7 to 9 ( Fig. 4A ). Then we examined the expression of c-4 Fos, an activity-dependent immediate early gene that is expressed in neurons following depolarization 5 and often used as a marker for mapping neuronal activity (Loebrich and Nedivi, 2009) . After culture in 6 BrainPhys medium, neuronal maturation and activity were significantly promoted in both DFOs and 7 VFOs, compared to the organoids cultured in the commonly used ND medium. As shown in Fig. 4A and   8 B, at week 9, there were significantly more c-Fos + cells in the organoids cultured in BrainPhys medium 9 than in ND medium. Furthermore, we observed that the synaptic markers, postsynaptic density protein 10 95 (PSD-95) and synapsin 1 were also expressed in the DFOs cultured in BrainPhys medium (Fig. 4C ).
11
Moreover, neurons expressing CUX1, a marker for superficial-layer cortical neurons (Nieto et al., 2004) 12 and neurons expressing TBR1 + , a marker for pre-plate/deep-layer neurons (Hevner et al., 2001) were 13 also seen in the DFOs (Fig. 4D) . A small population of Emx1 + dorsal NPCs was also found in DFOs 14 (6.45 ± 0.9%, n = 4; Fig. 4E and F). At this time point, GFP signals became undetectable in the DFOs.
15
In the VFOs, GFP fluorescence became much dimmer, compared to week 7 VFOs (Fig. 1G ). This may 16 result from the differentiation of a subset of OLIG2-expressing ventral forebrain NPCs to neurons, 17 particularly interneurons, and subsequent termination of OLIG2/GFP expression in those cells, as 18 reported in previous studies in mice (Miyoshi et al., 2007; Ono et al., 2008) .
20
Human PSC-derived organoids reveal the ventral and dorsal origins of oligodendrogenesis
21
To promote oligodendrogenesis in the DFOs and VFOs, we further cultured the organoids for an 22 additional 3 weeks ( Fig. 4A; week 9 to 12) in oligodendroglial differentiation medium containing thyroid 23 hormone T3, which is commonly used to promote oligodendroglial differentiation from hPSCs under 2D 24 culture conditions (Douvaras and Fossati, 2015; Hu et al., 2009; Liu et al., 2011; Nistor et al., 2005;  25 Piao et al., 2015; Stacpoole et al., 2013; Wang et al., 2013) . As shown in Fig. 1G , at week 12, there 26 were a large number of bright GFP + cells evenly distributed in the VFOs. In the DFOs, GFP signal 27 reappeared after the treatment of T3. To characterize the identity of these GFP + cells, we double-28 stained GFP with OPC marker PDGFRα. We found that in both VFOs and DFOs, nearly half of the 29 GFP + expressed PDGFRα, indicating the oligodendrogenesis in both organoids ( Fig. 4G and H) . A 30 subset of PDGFRα + OPCs in DFOs also exhibited immunoreactivity for Ki67, suggesting that these 31 OPCs were capable of proliferation ( Fig. 4I ). In addition, we also stained the organoids with S100β or 32 β IIIT, but found no GFP + cells expressing S100β or β IIIT at week 12 (data not shown). Thus, the 33 GFP + /PDGFRα-negative cells in the organoids might have committed to oligodendroglial fate but had
34 not yet expressed any OPC marker. To further validate the ventral vs. dorsal origin of the OPCs in
35
VFOs and DFOs, we examined the expression of tyrosine kinase B (TrkB). Previous studies (Du et al., 36 2003) have shown that TrkB is selectively expressed in oligodendroglia from the basal forebrain that 37 has a ventral origin (Kessaris et al., 2006; Klambt, 2009 ), but not expressed in oligodendroglia from 38 cerebral cortex that has a dorsal origin (Kessaris et al., 2006; Winkler et al., 2018) . We observed that
39
TrkB was robustly expressed by neurons in both VFOs and DFOs. However, only a small population of 40 TrkB + /GFP + cells were seen in VFOs but no TrkB + /GFP + cells in DFOs (Fig. 4J) . These results 41 demonstrate that further culturing VFOs and DFOs under conditions favoring oligodendroglial 42 differentiation can further reveal oligodendrogenesis with ventral and dorsal origins, respectively.
44
Oligodendroglial maturation in DFOs, VFOs, and fused forebrain organoids (FFOs)
45
To examine whether OPCs in these organoids were able to mature into myelinating oligodendrocytes,
46
we further cultured the VFOs and DFOs in OL medium up to 6 weeks. Moreover, to test whether the interregional interactions between the differentially patterned human forebrain organoids (Bagley et al., 48 2017; Birey et al., 2017; Xiang et al., 2017) are important for oligodendroglial maturation, we generated
49
FFOs and further cultured them in OL medium ( Fig. 5A ). VFOs at an early stage (week 5) were used for 50 fusion with DFOs because previous studies showed that immature migrating interneurons generated by 51 8 ventral forebrain NPCs promote oligodendrocyte formation in the cortex in a paracrine fashion 1 (Voronova et al., 2017) . After fusion, we observed a massive migration of GFP + cells from the VFOs 2 into the DFOs (Fig. 5B ), similar to the observations reported in previous studies (Bagley et al., 2017;  3 Birey et al., 2017; Xiang et al., 2017) . At 3 weeks after fusion (week 12), GFP + cells largely populated 4 the FFOs and exhibited bipolar morphology, characteristics of OPCs ( Fig. 5B ). At week 15, we 5 assessed oligodendroglial maturation in DFOs, VFOs, and FFOs by staining MBP, a marker for mature 6 oligodendrocytes. As shown in Fig. 5C and D, MBP + /GFP + cells were detected in VFOs (1.0 ± 0.4%, n 7 = 4), but not in DFOs. Interestingly, fusing the organoids significantly promote the maturation of 8 oligodendrocytes, as indicated by a higher percent of MBP + /GFP + cells in FFOs (8.4 ± 2.0%, n = 4).
9
The mature oligodendrocytes in FFOs exhibited complex processes at week 12 ( Fig. 5E, upper 
46

Dorsally-derived oligodendroglia outcompete ventrally-derived oligodendroglia in the FFOs
To further examine which population of oligodendroglia constituted the oligodendroglial cells in FFOs, 1 0
Discussion
2
The transcription factor Olig2 is not only closely associated with the development of oligodendrocytes in 3 the vertebrate CNS, but also is expressed in NPCs during development (Jiang et al., 2013; Ligon et al., 4 2006; Meijer et al., 2012; Ono et al., 2008) . It is well known that at early embryonic stages in mice,
5
Olig2 is mostly expressed in the brain by the NPCs that distribute in the ventral telencephalon (Ligon et   6 al., 2006; Meijer et al., 2012) . A distinct but small number of Olig2-expressing NPCs that distribute in 7 the dorsal region of the forebrain, specifically in the dorsal diencephalon, has been identified in both 8 mouse and human embryonic brain (Jakovcevski and Zecevic, 2005a; Ono et al., 2008) . We observed 9 distinct temporal expression patterns of OLIG2 in DFOs and VFOs. This was achieved by using our 10 OLIG2-GFP hPSC reporter lines, which allow us to monitor OLIG2 expression by real-time monitoring uncompacted myelin. This may be attributed in part to a lack of oxygen penetration in the organoids 13 cultured for long-term, which can result in necrosis in the core of organoids (Brawner et al., 2017;  14 Giandomenico and Lancaster, 2017) . As opposed to rodent OPCs, human OPC differentiation and 15 myelination are highly sensitive to hypoxic conditions (Gautier et al., 2015) . Future studies aiming at 16 integrating a vascular structure that brings the adequate delivery of oxygen and nutrients to organoids 17 and promoting neuronal maturation and electrical activity (Brawner et al., 2017; Mansour et al., 2018) 18 may help facilitate organoid models with robust oligodendroglial maturation.
19
Previous studies using transgenic mouse models have helped us understand the developmental 20 differences between ventrally-and dorsally-derived OPCs (Kessaris et al., 2006; Nery et al., 2001;  21 Orentas et al., 1999; Winkler et al., 2018) . However, it is largely unclear what the phenotypic and 22 functional differences are between the different populations of OPCs. Due to the scarcity of available 23 functional human brain tissue, no information is available on the differences in humans. In this study,
24
we demonstrate the generation of dorsally-and ventrally-derived human oligodendroglial cells in 25 organoids. We propose that the competitive advantage exhibited by dorsally-derived over ventrally- The OLIG2-GFP knockin hPSCs (hESCs and hiPSCs) were established using a gene-targeting 4 protocol and fully characterized, as reported in our previous studies (Liu et al., 2011; Xue et al., 2016) .
5
The OLIG2-GFP hiPSC reporter line was established from the ND2.0 hiPSC line that was obtained week 9, organoids were maintained in ND medium supplemented with 3,3,5-Triiodo-L-thyronine sodium 40 salt (T3; 10 ng/ml, Cayman Chem; OL medium) for oligodendroglial differentiation and maturation.
41
FFOs were generated by using a spontaneous fusion method ( 
20
Immunostaining and cell counting
21
Organoids fixed with 4% paraformaldehyde were processed and cryo-sectioned for 22 immunofluorescence staining. The information for primary antibodies and dilutions is listed in Table S2 .
23
Slides were mounted with the anti-fade Fluoromount-G medium containing 1,40,6-diamidino-2-24 phenylindole dihydrochloride (DAPI) (Southern Biotechnology). Images were captured with LSM800 25 confocal microscope. The cells were counted with ImageJ software. At least six fields chosen randomly 26 from three sections of each organoid were counted. For each organoid, at least 400 cells were counted.
28
Dye loading and calcium imaging
29
For calcium imaging in organoids, DFOs were placed on the growth factor-reduced Matrigel-coated 30 coverslip in 6-well plate for 24 hr. The next day, organoids were loaded with fluo-4 AM (5 µM, Molecular
31
Probes) and 0.04% Pluronic F-127 for 40 minutes and then transferred to the neuronal differentiation 32 (ND) medium for at least 30 minutes before transferring to the submersion-type recording chamber 33 (Warner) superfused at room temperature with artificial CSF (ACSF, mM: 126 NaCl, Organoid samples were fixed with 2% glutaraldehyde, 2% paraformaldehyde, and 0.1M sodium 1 cacodylate in PBS. The selected vibratome sections were post-fixed and processed for electron 2 microscopy (EM) as described in our previous studies (Chen et al., 2016; Jiang et al., 2016) . EM 3 images were captured using a high-resolution charge-coupled device (CCD) camera (FEI). 31 32 
41
(B) Quantification of Ca 2+ transients. Two distinct patterns of Ca 2+ transients were identified: type 1 42 "glial cell-like pattern (green) and type 2 "neuron-like" pattern (red). Scale bars represent 50 s and 100% 43 ΔF/F. Quantification for the number, peak value, and duration of the Ca 2+ transients (n = 5 fields from 2 44 organoids) are shown. (A) A schematic procedure for fusing the VFOs and DFOs that were respectively derived from isogenic 1 OLIG2-GFP hiPSC reporter line and ND2.0 hiPSC line that do not have any reporter fluorescence.
(B and C) Representative images and quantification showing that ventrally-derived OLIG+ cells (GFP + )
3 are outnumbered by dorsally-derived OLIG2 + cells (GFP-negative) at one week after fusion (week 10) 4 to six weeks after fusion (week 15). Scale bar, 100 µm. Student's t-test., ***p < 0.001.
5
(D and E) Representative images and quantification showing the MBP + cells with a ventral (GFP + ) or 6 dorsal (GFP-negative) origin. Scale bars, 50 µm. Student's t-test., ***p < 0.001. 7 8 9 10 11 12 13
